ClinicalTrials.Veeva

Menu

Mechanical Power-Guided Lung Protective Ventilation (VentCoach) in Acute Hypoxemic and/or Hypercapnic Respiratory Failure

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Mechanical Ventilation

Treatments

Other: Standard of Care
Other: VentCoach

Study type

Interventional

Funder types

Other

Identifiers

NCT07294768
23-004855

Details and patient eligibility

About

The purpose of this research is to evaluate a different way of using the mechanical ventilator device to help better protect the lungs while the patient recovers. We will compare VentCoach to the current standard mechanical ventilation techniques used in our Intensive Care Units.

Enrollment

18 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with acute hypoxemic and/or hypercapnic respiratory failure.
  • Patients requiring intubation and mechanical ventilation for more than 24 hours.
  • VentCoach protocol is specific to volume controlled continuous mandatory ventilation (S-CMV).
  • Patient who are admitted to RMH 10-3/10-4 and MB 6BGF ICUs.
  • Age greater than or equal to 18 years.
  • Patient's legal representative should be able to provide informed consent to the study. Any participant speaking any language will be offered participation.

Exclusion criteria

  • Intubation and mechanical ventilation for airway protection in the setting of procedures/surgeries, e.g. interventional radiology, surgery, or endoscopy.
  • Intubation and mechanical ventilation due to drug overdose with expected extubation of less than 24 hours.
  • Intubation and mechanical ventilation in the setting of cardiac arrest.
  • Intubation and mechanical ventilation for a primary neurological etiology, e.g. increased intracranial pressure, tumor mass effect, ischemic/hemorrhagic stroke, status epilepticus, etc.
  • Mechanical ventilation to be guided by esophageal balloon.
  • Subject deprived of freedom, minor, subject under a legal protective measure.
  • Change in end-of-life decision anticipated after enrollment (or estimated 6-month mortality rate of greater than 50%).

Note: prone positioning is not a contraindication for participation.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

18 participants in 2 patient groups

Standard of Care
Active Comparator group
Description:
Patients randomized to the standard of care group will continue to receive ventilator management per the ARDSnet-based protocol
Treatment:
Other: Standard of Care
VentCoach
Experimental group
Description:
Patients randomized to the VentCoach group, in addition to the standard of care, will also receive intermittent ventilator setting adjustments per the VentCoach protocol
Treatment:
Other: Standard of Care
Other: VentCoach

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems